Literature DB >> 19401386

PPARgamma regulates retinoic acid-mediated DC induction of Tregs.

William J Housley1, Catherine A O'Conor, Frank Nichols, Lynn Puddington, Elizabeth G Lingenheld, Li Zhu, Robert B Clark.   

Abstract

CD4+ CD25+ Foxp3+ Tregs are critical regulators of immune responses and autoimmune diseases. nTregs are thymically derived; iTregs are converted in the periphery from CD4+ CD25- Foxp3- Teffs. Recent studies reported that GALT CD103+ DCs mediated enhanced iTreg conversion via the secretion of RA. However, the factors regulating RA secretion and hence, the induction of iTregs by DCs are not yet clear. Activation of the nuclear hormone receptor PPARgamma has been shown to induce RA expression in human DCs, and thus, we postulated that PPARgamma activation in DCs may be an important regulator of RA secretion and iTreg generation. Using in vitro and in vivo approaches, we now demonstrate that PPARgamma activation enhances iTreg generation through increased RA synthesis from murine splenic DCs. In addition, we demonstrate that inhibition of DC PPARgamma decreases iTreg generation, suggesting a role for endogenous PPARgamma ligands in this process. Overall, our findings suggest that PPARgamma may be important as a factor that stimulates DCs to produce RA and as a potential mechanism by which PPARgamma ligands ameliorate autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401386      PMCID: PMC2814813          DOI: 10.1189/jlb.1208733

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  35 in total

1.  Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.

Authors:  Lawrence J Saubermann; Atsushi Nakajima; Koichiro Wada; Shuping Zhao; Yasuo Terauchi; Takashi Kadowaki; Hiroyuki Aburatani; Nobuyuki Matsuhashi; Ryozo Nagai; Richard S Blumberg
Journal:  Inflamm Bowel Dis       Date:  2002-09       Impact factor: 5.325

2.  Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.

Authors:  C Natarajan; J J Bright
Journal:  Genes Immun       Date:  2002-04       Impact factor: 2.676

3.  Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

Authors:  Lisa M Leesnitzer; Derek J Parks; Randy K Bledsoe; Jeff E Cobb; Jon L Collins; Thomas G Consler; Roderick G Davis; Emily A Hull-Ryde; James M Lenhard; Lisa Patel; Kelli D Plunket; Jennifer L Shenk; Julie B Stimmel; Christina Therapontos; Timothy M Willson; Steven G Blanchard
Journal:  Biochemistry       Date:  2002-05-28       Impact factor: 3.162

4.  Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.

Authors:  Petra Augstein; Annemarie Dunger; Peter Heinke; Gerhild Wachlin; Sabine Berg; Bernd Hehmke; Eckhard Salzsieder
Journal:  Biochem Biophys Res Commun       Date:  2003-05-02       Impact factor: 3.575

5.  Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.

Authors:  Chandramohan Natarajan; Gladson Muthian; Yaavov Barak; Ronald M Evans; John J Bright
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

Review 6.  Emerging roles of PPARs in inflammation and immunity.

Authors:  Raymond A Daynes; Dallas C Jones
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

7.  Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.

Authors:  Hamida Hammad; Hendrik Jan de Heer; Thomas Soullié; Véronique Angeli; François Trottein; Henk C Hoogsteden; Bart N Lambrecht
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

8.  Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma.

Authors:  Cynthia Mueller; Veronika Weaver; John P Vanden Heuvel; Avery August; Margherita T Cantorna
Journal:  Arch Biochem Biophys       Date:  2003-10-15       Impact factor: 4.013

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation.

Authors:  Gaetane Woerly; Kohei Honda; Marc Loyens; Jean-Paul Papin; Johan Auwerx; Bart Staels; Monique Capron; David Dombrowicz
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  16 in total

Review 1.  Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance.

Authors:  Barbara Cassani; Eduardo J Villablanca; Jaime De Calisto; Sen Wang; J Rodrigo Mora
Journal:  Mol Aspects Med       Date:  2011-11-22

2.  Agonistic induction of PPARγ reverses cigarette smoke-induced emphysema.

Authors:  Ming Shan; Ran You; Xiaoyi Yuan; Michael V Frazier; Paul Porter; Alexander Seryshev; Jeong-Soo Hong; Li-zhen Song; Yiqun Zhang; Susan Hilsenbeck; Lawrence Whitehead; Nazanin Zarinkamar; Sarah Perusich; David B Corry; Farrah Kheradmand
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

3.  Cutting Edge: Dual Function of PPARγ in CD11c+ Cells Ensures Immune Tolerance in the Airways.

Authors:  Anupriya Khare; Krishnendu Chakraborty; Mahesh Raundhal; Prabir Ray; Anuradha Ray
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

Review 4.  Metabolic control of the Treg/Th17 axis.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

5.  RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells.

Authors:  Adrienn Gyöngyösi; Istvan Szatmari; Attila Pap; Balazs Dezso; Zoltan Pos; Lajos Széles; Tamas Varga; Laszlo Nagy
Journal:  J Lipid Res       Date:  2013-07-06       Impact factor: 5.922

6.  Effects of 15d-PGJ₂-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation.

Authors:  Cf Alves; Nfs de Melo; Lf Fraceto; Dr de Araújo; Mh Napimoga
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

7.  Peroxisome proliferator-activated receptor gamma is required for CD4+ T cell-mediated lymphopenia-associated autoimmunity.

Authors:  William J Housley; Catherine O Adams; Amanda G Vang; Stefan Brocke; Frank C Nichols; Melissa LaCombe; Thiruchandurai V Rajan; Robert B Clark
Journal:  J Immunol       Date:  2011-09-09       Impact factor: 5.422

8.  Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients.

Authors:  B M Brooks-Worrell; J P Palmer
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

9.  Differential role of all-trans retinoic acid in promoting the development of CD4+ and CD8+ regulatory T cells.

Authors:  Jilin Ma; Ya Liu; Yang Li; Jian Gu; Justin Liu; Jiayou Tang; Julie Wang; Bernhard Ryffel; Yi Shen; David Brand; Zhongmin Liu; Song Guo Zheng
Journal:  J Leukoc Biol       Date:  2013-09-30       Impact factor: 4.962

Review 10.  Aldehyde dehydrogenase in regulatory T-cell development, immunity and cancer.

Authors:  Christopher G Bazewicz; Saketh S Dinavahi; Todd D Schell; Gavin P Robertson
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.